|
|
||||||||
The Journal of Immunology, Vol 154, Issue 5 2092-2103, Copyright © 1995 by American Association of Immunologists
ARTICLES |
O Rott, J Charreire, M Semichon, G Bismuth and E Cash
INSERM U.283, Cochin Hospital, Rene Descartes University, Paris, France.
The influenza virus hemagglutinin glycoprotein (HA) induces a vigorous B cell proliferation and Ig-synthesis by an unknown activation mechanism, which is susceptible to the inhibitory effects of anti-Ig and anti-class II mAbs. To gain further insight into the activation mode of this T cell-independent, B cell "superstimulatory" virus, we analyzed the sensitivity of H2-subtype virus-mediated B cell activation to the inhibitory effects of various signal transduction-blocking agents and compared it to the well characterized anti-mu-mediated and the LPS-employed pathway. Cyclic-AMP agonists (cAMP-analogues, pentoxifylline, cholera toxin, and forskolin) blocked HA-mediated activation of B cells only at concentrations at least 50-fold higher than required for blocking of anti-mu-induced activation. However, HA- treatment failed to induce an increase in intracellular cAMP levels in responding B cells. The B cell response to HA was highly resistant to calcineurin-inhibitory cyclosporin-A treatment and did not result in a measurable Ca2+ influx. Similarly, HA failed to induce an increase in tyrosine phosphorylations, including phosphorylation of phospholipase C gamma 2. HA-activated B cells showed an increase in membrane-associated protein kinase C activity, and depletion of protein kinase C by pretreatment of B cells with phorbol esters inhibited a subsequent activation by HA. Collectively, our results provide a new example of B cell stimulation by multivalent type-2 Ags, which seems to be mediated by a phosphatidylinositol- and Ca(2+)-independent signaling pathway.
This article has been cited by other articles:
![]() |
Y.-K. Shin, Q. Liu, S. K. Tikoo, L. A. Babiuk, and Y. Zhou Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation J. Gen. Virol., March 1, 2007; 88(3): 942 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Kang, L. Guo, Q. Yao, I. Skountzou, and R. W. Compans Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens J. Virol., September 15, 2004; 78(18): 9624 - 9632. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Chen, S. Seth, G. Yue, P. Kamat, R. W. Compans, D. Guidot, L. A. Brown, D. C. Eaton, and L. Jain Influenza virus inhibits ENaC and lung fluid clearance Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L366 - L373. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mey and J.-P. Revillard Mitogenic Response of Murine B Lymphocytes to Salmonella typhimurium Lipopolysaccharide Requires Protein Kinase C-Dependent Late Tyrosine Phosphorylations Infect. Immun., June 1, 1998; 66(6): 2547 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunzelmann, A. H. Beesley, N. J. King, G. Karupiah, J. A. Young, and D. I. Cook From the Cover: Influenza virus inhibits amiloride-sensitive Na+ channels in respiratory epithelia PNAS, August 29, 2000; 97(18): 10282 - 10287. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |